BENGALURU, India, Aug. 5, 2024 /PRNewswire/ -- Skanray, a leading
global MedTech R&D and Manufacturing company specialising in
diagnostic imaging, critical care and surgery/OT solutions, has
chosen Tata Elxsi as a strategic partner for advanced surgical
imaging core technology and software platform development. This
collaboration aims to revolutionise diagnosis and treatment by
leveraging cutting-edge technology modules, making them
predictable, accurate, and consistent.
Skanray is actively pursuing a long-term strategy to expand its
portfolio by including new device families and modalities. This
initiative aims to build a suite of reusable modules and components
for medical devices, alongside the development of an advanced
analytics cloud platform.
Tata Elxsi will lead a software platform-led approach to
diagnostics that will support all imaging, critical care and
surgical systems from the Skanray family, ensuring
interoperability, compatibility and multi-modal functionality. This
platform will also incorporate the latest technologies and process
efficiencies from AI and GenAI.
Combining Skanray's expertise in medical devices, core component
technology, systems and applications with Tata Elxsi's domain
experience in medical imaging, software platform development,
digital capabilities in cloud, AI and analytics, and ready-to-use
solution accelerators provides Skanray an opportunity to redefine
the landscape of medical technology, with advanced, modular, and
yet affordable diagnostics systems.
Pankaj Madhukar Wani, Head of
Healthcare Business Unit at Tata Elxsi, said,
"The diagnostic imaging landscape is being transformed by
software and digital technologies such as cloud and AI. We are
delighted to be supporting Skanray in realising their long-term
strategy and vision for healthcare. This long-term partnership will
help create transformative solutions for healthcare facilities and
patients worldwide."
"By combining Skanray's core technology and deep
understanding of medical applications with Tata Elxsi's
capabilities in futuristic technology, we are poised to drive
significant advancements in healthcare delivery. Our collaborative
efforts will result in solutions that are not only technologically
advanced, but are also operator-friendly and cost-effective,
helping healthcare providers deliver significantly improved health
outcomes for patients," said Priyanka Chatterjee, VP – Corporate
Communications at Skanray Technologies Ltd.
About Tata Elxsi
Tata Elxsi is a global design and technology services company
headquartered in Bangalore. It
addresses the healthcare, automotive, broadcast, and communications
consumer electronics industries. This is supported by a network of
design studios, development centres, and offices worldwide.
Tata Elxsi's Healthcare & Life Sciences practice is ISO
13485 certified and collaborates with prominent medical device and
pharmaceutical OEMs, as well as technology companies. With a
comprehensive services and solutions portfolio, Tata Elxsi adds
value at every stage of the customer's product development
lifecycle. Recognised as a leader in technology consulting, new
product design, development, verification & validation, as well
as regulatory compliance services, Tata Elxsi is a trusted name in
the industry.
About Skanray
Skanray is a leading MedTech R&D company with operations in
7 countries . Skanray offers 55 CE marked and 34 FDA approved
products in diagnostics imaging, critical care, cardiology, dental
and in the surgical space.
With a portfolio boasting over 80 patents, Skanray contributes
to more than 150,000 installations in 80 countries, across the
globe.
Logo:
https://mma.prnewswire.com/media/742257/Tata_Elxsi_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/skanray-partners-with-tata-elxsi-to-advance-surgical-imaging-and-healthcare-innovation-302214141.html